71 West Capital Partners’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$431K Buy
339,515
+179,466
+112% +$338K 0.02% 185
2025
Q4
$383K Buy
+160,049
New +$438K 0.02% 167

Other funds holding HCAT

71 West Capital Partners's HCAT Position: Q1 2026 in Review

71 West Capital Partners increased its Health Catalyst (HCAT) stake by 112% in Q1 2026, buying an estimated $338K and bringing the position to 339,515 shares worth $431K. The position accounts for 0.02% of the portfolio, ranked #185.

71 West Capital Partners first reported a position in HCAT in Q4 2025 and has held it in 2 quarters since. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • 71 West Capital Partners held 339,515 shares of Health Catalyst worth $431K as of Q1 2026.
  • 71 West Capital Partners bought 179,466 Health Catalyst shares in Q1 2026, an estimated $338K.
  • Health Catalyst made up 0.02% of 71 West Capital Partners's portfolio in Q1 2026, its #185 holding.
  • 71 West Capital Partners first reported a position in Health Catalyst in Q4 2025 and has held it in 2 quarters since.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on 71 West Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.